Page 152 - FBL AR 2019-20

Fermenta Biotech Limited
Annual Report 2019-20

Notes to the Standalone financial statements for the year ended March 31, 2020

40 Related parties disclosures as per Ind AS 24 (contd.)
( H in Lakhs )
Sr. Particulars Holding Subsidiaries Key Enterprise Joint
No. Company management significantly ventures /
personnel* influenced by associates
KMP or their
relatives
14 Loans taken
DVK Investments Private Limited - - - - -
(50.00) ( - ) ( - ) ( - ) ( - )
15 Interest on loan taken
DVK Investments Private Limited 4.60 - - - -
(26.92) ( - ) ( - ) ( - ) ( - )
16 Loans repaid
DVK Investments Private Limited 250.00 - - - -
( - ) ( - ) ( - ) ( - ) ( - )
(Figures in brackets are the corresponding figures in respect of the previous year.)

* The remuneration to the key managerial personnel does not include the provisions made for gratuity and leave benefits, as they are
determined on an actuarial basis for the company as a whole.
C) Balance outstanding as at the end of the year:
( H in Lakhs )
March 31, 2020 March 31, 2019
a. Trade payables and reimbursement payables
Subsidiary
Aegean Properties Limited. 87.89 68.49
Fermenta Biotech Gmbh 655.50 -
Enterprises under significant influence of key management personnel or their relatives:
Lacto Cosmetics (Vapi) Pvt Ltd - 1.36
b. Trade receivables and reimbursement receivables
Subsidiary
CC Square Films Limited 5.57 5.57
Aegean Properties Limited. 11.50 1.70
Fermenta Biotech Gmbh 840.19 -
Enterprises under significant influence of key management personnel or their relatives:
Dupen Laboratories Pvt Ltd 22.45 10.33
c. Allowance for doubtful debts/advances
Associate
Health and Wellness India Private Limited 37.00 37.00
Subsidiary
CC Square Films Limited 5.52 5.52
d. Deposit from tenants
Associate of Holding Company
Silk Road Communications Private Limited 0.20 0.20
e. Provision for diminution in value of investments
Associates
Zela Wellness Private Limited 78.99 78.99
Health and Wellness India Private Limited (including share application money) 784.86 784.86
Subsidiary
CC Square Films Limited 5.00 5.00
Fermenta Biotech (UK) Limited 148.65 148.65
f. Provision for share of loss in a joint venture in excess of cost of investment
Joint venture
Agastya Films LLP 13.02 13.02

150